Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study
Design and Objective
The aim of the ADVANCE-ON Follow-Up study was to check the long term effects, risks and benefits after the ADVANCE trial treatments had stopped. The two treatments were a low-dose perindopril-indapamide combination for controlling blood pressure compared with a dummy tablet and intensive glucose control with a modified release gliclazide (gliclazide MR)-based regimen compared with usual care.
Key inclusion criteria
•Participated in ADVANCE trial •Ability to provide informed consent
Study Disclaimer Statement